Saudi SFDA Launches NADR Program to Accelerate Rare Disease Drug Access (ipharmacenter.com)
The Saudi Food and Drug Authority has introduced the New Accelerator Program for Drugs in Rare Diseases, known as NADR, to support the development, registration, and faster availability of medicines f...
Saudi-Arabien startet NADR, um Entwicklung, Zulassung und Zugang zu Arzneimitteln für seltene Krankheiten zu beschleunigen.
www.ipharmacenter.com/post/saudi-s...